Botulinum neurotoxin (BoNT) injections, the most common non-surgical cosmetic technique, are gaining popularity among all cosmetic practitioners worldwide. This page will keep readers up to speed on novel botulinum toxins that are currently under research or nearing the market in the United States and Canada, such as daxbotulinum toxin A, prabotulinumtoxin A, letibotulinumtoxin A, and botulinum toxin E.
Despite having similar characteristics and clinical efficacies, these neurotoxins have a number of distinct potential advantages that will be discussed in this review, including but not limited to a longer duration of action, the absence of animal-derived components or human albumin, and a rapid onset with short duration of action.
Reference:https://link.springer.com/article/10.1007/s40257-019-00482-2
